In 2010 further funding from NIH/National Institute of Allergy and Infectious Diseases (NIAID) for the study of the "Abeta protein of Alzheimer's Disease is an antimicrobial peptide" and in 2019, again from the NIH/NIA for research into the "Antimicrobial activities of Abeta in Alzheimer's disease brain".